Toll-like receptor 3 in liver diseases

Gastroenterology Research and Practice

Volumn , Issue , 2010, Pages

  Gao, Bin ^a   Yin, Shi ^a,b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 3;

AUTOIMMUNE DISEASE; HUMAN; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; LIVER REGENERATION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; VIRUS HEPATITIS;

EID: 78349278105     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2010/750904     Document Type: Review

References (58)

1. Trivedi S., Greidlinger E. L., Endosomal Toll-like receptors in autoimmunity: mechanisms for clinical diversity Therapy 2009 6 3 433 442
2. Kenny E. F., O'Neill L. A. J., Signalling adaptors used by Toll-like receptors: an update Cytokine 2008 43 3 342 349
3. Vercammen E., Staal J., Beyaert R., Sensing of viral infection and activation of innate immunity by toll-like receptor 3 Clinical Microbiology Reviews 2008 21 1 13 25
4. Schrder M., Bowie A. G., TLR3 in antiviral immunity: key player or bystander? Trends in Immunology 2005 26 9 462 468
5. Seki E., Brenner D. A., Toll-like receptors and adaptor molecules in liver disease: update Hepatology 2008 48 1 322 335
6. Szabo G., Dolganiuc A., Mandrekar P., Pattern recognition receptors: a contemporary view on liver diseases Hepatology 2006 44 2 287 298
7. Mencin A., Kluwe J., Schwabe R. F., Toll-like receptors as targets in chronic liver diseases Gut 2009 58 5 704 720
8. Khvalevsky E., Rivkin L., Rachmilewitz J., Galun E., Giladi H., TLR3 signaling in a hepatoma cell line is skewed towards apoptosis Journal of Cellular Biochemistry 2007 100 5 1301 1312
9. Li K., Chen Z., Kato N., Gale M. Jr., Lemon S. M., Distinct poly(I-C) and virus-activated signaling pathways leading to interferon- production in hepatocytes Journal of Biological Chemistry 2005 280 17 16739 16747
10. Wang N., Liang Y., Devaraj S., Wang J., Lemon S. M., Li K., Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells Journal of Virology 2009 83 19 9824 9834
11. Wang B., Trippler M., Pei R., Lu M., Broering R., Gerken G., Schlaak J. F., Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication Journal of Hepatology 2009 51 6 1037 1045
12. Xiao X., Zhao P., Rodriguez-Pinto D., Qi D., Henegariu O., Alexopoulou L., Flavell R. A., Wong F. S., Wen L., Inflammatory regulation by TLR3 in acute hepatitis Journal of Immunology 2009 183 6 3712 3719
13. Nakamura M., Funami K., Komori A., Yokoyama T., Aiba Y., Araki A., Takii Y., Ito M., Matsuyama M., Koyabu M., Migita K., Taniguchi K., Fujioka H., Yatsuhashi H., Matsumoto M., Ishibashi H., Seya T., Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers Hepatology International 2008 2 2 222 230
14. Takii Y., Nakamura M., Ito M., Yokoyama T., Komori A., Shimizu-Yoshida Y., Nakao R., Kusumoto K., Nagaoka S., Yano K., Abiru S., Ueki T., Matsumoto T., Daikoku M., Taniguchi K., Fujioka H., Migita K., Yatsuhashi H., Nakashima M., Harada M., Ishibashi H., Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis Laboratory Investigation 2005 85 7 908 920 (Pubitemid 41021299)
15. Gardner T., Chen Q., Jin Y., Ajuber M., Toll-like receptor 3 ligand dampens liver inflammation by stimulating Valpha14 invariant natural killer T cells to negatively regulate gamma/delta T cells American Journal of Pathology 2010 176 5 1779 1789
16. Wiltrout R. H., Mathieson B. J., Talmadge J. E., Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver Journal of Experimental Medicine 1984 160 5 1431 1449
17. Wiltrout R. H., Pilaro A. M., Gruys M. E., Talmadge J. E., Longo D. L., Ortaldo J. R., Reynolds C. W., Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow Journal of Immunology 1989 143 1 372 378
18. Wang J., Xu J., Zhang W., Wei H., Tian Z., TLR3 ligand-induced accumulation of activated splenic natural killer cells into liver Cellular Molecular of Immunology 2005 2 6 449 453
19. Zhang M., Han Y., Han C., Xu S., Bao Y., Chen Z., Gu Y., Xia D., Cao X., The beta2 integrin CD11b attenuates polyinosinic:polycytidylic acid-induced hepatitis by negatively regulating natural killer cell functions Hepatology 2009 50 5 1606 1616
20. Dong Z., Wei H., Sun R., Hu Z., Gao B., Tian Z., Involvement of natural killer cells in PolyI:C-induced liver injury Journal of Hepatology 2004 41 6 966 973
21. Alexopoulou L., Holt A. C., Medzhitov R., Flavell R. A., Recognition of double-stranded RNA and activation of NF- B by Toll-like receptor 3 Nature 2001 413 6857 732 738
22. Hou X., Zhou R., Wei H., Sun R., Tian Z., NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis Hepatology 2009 49 3 940 949
23. Chen Y., Sun R., Jiang W., Wei H., Tian Z., Liver-specific HBsAg transgenic mice are over-sensitive to Poly(I:C)-induced liver injury in NK cell- and IFN- -dependent manner Journal of Hepatology 2007 47 2 183 190
24. Chen Y., Wei H., Sun R., Dong Z., Zhang J., Tian Z., Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells Hepatology 2007 46 3 706 715
25. Jiang W., Sun R., Wei H., Tian Z., Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages Proceedings of the National Academy of Sciences of the United States of America 2005 102 47 17077 17082
26. Michalopoulos G. K., Liver regeneration Journal of Cellular Physiology 2007 213 2 286 300
27. Seki E., Tsutsui H., Iimuro Y., Naka T., Son G., Akira S., Kishimoto T., Nakanishi K., Fujimoto J., Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration Hepatology 2005 41 3 443 450
28. Campbell J. S., Riehle K. J., Brooling J. T., Bauer R. L., Mitchell C., Fausto N., Proinflammatory cytokine production in liver regeneration is Myd88-dependent, but independent of Cd14, Tlr2, and Tlr4 Journal of Immunology 2006 176 4 2522 2528
29. Zorde-Khvalevsky E., Abramovitch R., Barash H., Spivak-Pohis I., Rivkin L., Rachmilewitz J., Galun E., Giladi H., Toll-like receptor 3 signaling attenuates liver regeneration Hepatology 2009 50 1 198 206
30. Shen K., Zheng S.-S., Park O., Wang H., Sun Z., Gao B., Activation of innate immunity (NK/IFN- ) in rat allogeneic liver transplantation: contribution to liver injury and suppression of hepatocyte proliferation American Journal of Physiology 2008 294 4 G1070 G1077
31. Sun R., Gao B., Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon- ) Gastroenterology 2004 127 5 1525 1539
32. Sun R., Park O., Horiguchi N., Kulkarni S., Jeong W.-I., Sun H.-Y., Radaeva S., Gao B., STAT1 contributes to dsRNA inhibition of liver regeneration after partial hepatectomy in mice Hepatology 2006 44 4 955 966
33. Bataller R., Brenner D. A., Liver fibrosis Journal of Clinical Investigation 2005 115 4 209 218
34. Friedman S. L., Mechanisms of Hepatic Fibrogenesis Gastroenterology 2008 134 6 1655 1669
35. Seki E., De Minicis S., sterreicher C. H., Kluwe J., Osawa Y., Brenner D. A., Schwabe R. F., TLR4 enhances TGF- signaling and hepatic fibrosis Nature Medicine 2007 13 11 1324 1332
36. Radaeva S., Sun R., Jaruga B., Nguyen V. T., Tian Z., Gao B., Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners Gastroenterology 2006 130 2 435 452
37. Jeong W.-I., Park O., Radaeva S., Gao B., STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity Hepatology 2006 44 6 1441 1451
38. Krizhanovsky V., Yon M., Dickins R. A., Hearn S., Simon J., Miething C., Yee H., Zender L., Lowe S. W., Senescence of activated stellate cells limits liver fibrosis Cell 2008 134 4 657 667
39. Mallat A., Preaux A.-M., Blazejewski S., Rosenbaum J., Dhumeaux D., Mavier P., Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture Hepatology 1995 21 4 1003 1010
40. Pan H.-N., Sun R., Jaruga B., Hong F., Kim W.-H., Gao B., Chronic ethanol consumption inhibits hepatic natural killer cell activity and accelerates murine cytomegalovirus-induced hepatitis Alcoholism: Clinical and Experimental Research 2006 30 9 1615 1623
41. Jeong W., Park O., Gao B., Abrogation of the antifibrotic effects of natural killer cells/interferon- contributes to acohol acceleration of liver fibrosis Gastroenterology 2008 134 1 248 258
42. Hbert P., Pruett S. B., Ethanol suppresses polyinosinic:polycytidylic acid-induced activation of natural killer cells primarily by acting on natural killer cells, not through effects on other cell types Alcohol 2002 28 2 75 81
43. Collier S. D., Pruett S. B., Mechanisms of suppression of poly I:C-induced activation of NK cells by ethanol Alcohol 2000 21 1 87 95
44. Wei H., Wei H., Wang H., Tian Z., Sun R., Activation of natural killer cells inhibits liver regeneration in toxin-induced liver injury model in mice via a tumor necrosis factor-alpha-dependent mechanism American Journal of Physiology 2010 299 1 G275 G282
45. Isogawa M., Robek M. D., Furuichi Y., Chisari F. V., Toll-like receptor signaling inhibits hepatitis B virus replication in vivo Journal of Virology 2005 79 11 7269 7272
46. Wu J., Lu M., Meng Z., Trippler M., Broering R., Szczeponek A., Krux F., Dittmer U., Roggendorf M., Gerken G., Schlaak J. F., Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice Hepatology 2007 46 6 1769 1778
47. Kanda T., Steele R., Ray R., Ray R. B., Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human hepatocytes Journal of Virology 2007 81 22 12375 12381
48. Perrin-Cocon L., Agaugu S., Diaz O., Vanbervliet B., Dollet S., Guironnet-Paquet A., Andr P., Lotteau V., Th 1 disabled function in response to TLR4 stimulation of monocyte-derived DC from patients chronically-infected by Hepatitis C virus PLoS One 2008 3 5
49. Duluc D., Tan F., Scotet M., Blanchard S., Frmaux I., Garo E., Horvat B., Eid P., Delneste Y., Jeannin P., PolyI:C plus IL-2 or IL-12 induce IFN- production by human NK cells via autocrine IFN- European Journal of Immunology 2009 39 10 2877 2884
50. Li N., Li Q., Qian Z., Zhang Y., Chen M., Shi G., Impaired TLR3/IFN- signaling in monocyte-derived dendritic cells from patients with acute-on-chronic hepatitis B liver failure: relevance to the severity of liver damage Biochemical and Biophysical Research Communications 2009 390 3 630 635
51. Li K., Foy E., Ferreon J. C., Nakamura M., Ferreon A. C. M., Ikeda M., Ray S. C., Gale M. Jr., Lemon S. M., Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF Proceedings of the National Academy of Sciences of the United States of America 2005 102 8 2992 2997
52. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., Tschopp J., Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus Nature 2005 437 7062 1167 1172
53. Foy E., Li K., Sumpter R. Jr., Loo Y.-M., Johnson C. L., Wang C., Fish P. M., Yoneyama M., Fujita T., Lemon S. M., Gale M. Jr., Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling Proceedings of the National Academy of Sciences of the United States of America 2005 102 8 2986 2991
54. Askar E., Bregadze R., Mertens J., Schweyer S., Rosenberger A., Ramadori G., Mihm S., TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C Journal of Medical Virology 2009 81 7 1204 1211
55. Lang K. S., Georgiev P., Recher M., Navarini A. A., Bergthaler A., Heikenwalder M., Harris N. L., Junt T., Odermatt B., Clavien P.-A., Pircher H., Akira S., Hengartner H., Zinkernagel R. M., Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling Journal of Clinical Investigation 2006 116 9 2456 2463
56. Okada C., Akbar F., Horiike N., Onji M., Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration Liver International 2005 25 3 595 603
57. Jiang T., Han Z., Chen S., Wu C., Tang Y., Qian C., Chen Y., Zhou Y., Zhu Y., Gu M., Zhu L., Yao D., Deng A., Zhong R., Resistance to activation-induced cell death and elevated FLIPL expression of CD4+ T cells in a polyI:C-induced primary biliary cirrhosis mouse model Clinical and Experimental Medicine 2009 9 4 269 276
58. Mao T. K., Lian Z.-X., Selmi C., Ichiki Y., Ashwood P., Ansari A. A., Coppel R. L., Shimoda S., Ishibashi H., Gershwin M. E., Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis Hepatology 2005 42 4 802 808